Chronic cough market seen reaching $14.17 billion by 2030
The Business Research Company says the global chronic cough market will grow from $8.87 billion in 2025 to $14.17 billion by 2030, powered by smoking-related illness, better diagnostics and rising demand for non-opioid treatments. North America held the largest share in 2025, while the report flags growth across multiple regions and treatment channels.
Why it matters: - Chronic cough is tied to common respiratory conditions and can signal underlying disease, so market growth reflects broader demand for diagnosis and treatment. - The forecast points to expanding need for therapies that are more targeted and less opioid-based. - Smoking-related cough drivers also connect the market to a large, ongoing public health burden.
What happened: - The Business Research Company released its Chronic Cough Global Market Report 2026, covering market size, trends and forecasts through 2035. - The report values the chronic cough market at $8.87 billion in 2025. - The market is projected to reach $9.71 billion in 2026, representing 9.4% annual growth. - The market is forecast to hit $14.17 billion by 2030, at a 9.9% compound annual growth rate. - North America held the largest market share in 2025.
The details: - The report links growth to higher asthma and allergy rates, broader awareness of chronic respiratory diseases and more over-the-counter cough remedies. - Better diagnostic tools and wider outpatient respiratory care services are also supporting demand. - Personalized therapies, higher investment in new cough treatments and demand for non-opioid options are expected to support longer-term growth. - Chronic cough is defined as a persistent cough lasting at least eight weeks. - Chronic cough can point to asthma, allergies or respiratory infections. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - The report says each region has different growth patterns based on respiratory disease prevalence, healthcare infrastructure and treatment access. - The 2026 edition adds market attractiveness scoring, total addressable market analysis, a company scoring matrix, Excel-based forecasting dashboards, market hotspots infographics and updated graphics and tables. - The report also includes key technologies and future trend analysis. - A free sample is available here. - The full report is available here.
Between the lines: - The market’s growth is being driven by both treatment innovation and a larger pool of patients with chronic respiratory symptoms. - Smoking remains a major demand driver because it contributes to airway irritation, chronic bronchitis, mucus production and reduced lung function. - The emphasis on non-opioid and personalized treatments suggests the market is moving toward more targeted care models.
What's next: - The market is expected to keep growing through 2030 as diagnostic access improves and more patients seek care. - Investment in new therapies and outpatient respiratory services is likely to remain a key growth lever. - Regional demand will likely continue to vary based on disease burden and healthcare access.
The bottom line: - Chronic cough is shifting from a symptom treated with basic remedies to a larger, faster-growing market for targeted respiratory care.
Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.
Sign up for:
One World Daily Brief
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.